Skip to content
ApprovedFDA approvedATC · N06BA07Rx · Prescription only (Rx), DEA Schedule IV (USA), specialist recommended in HU

Modafinil

Prescription wakefulness-promoting medicine for narcolepsy, shift-work sleep disorder and sleepiness that remains in sleep apnea.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Modafinil vial

Related comparisons

Modafinil vs Methylphenidate

DETAILED OVERVIEW

What is Modafinil?

Modafinil is a prescription medicine that keeps you awake without revving up the whole nervous system the way classic stimulants do. It is approved for narcolepsy (lasting daytime sleepiness), sleep problems caused by shift work, and leftover sleepiness in sleep apnea (breathing pauses during sleep); in studies it reduced sleepiness in these conditions. In the United States it is a controlled substance, because the risk of misuse and psychological dependence is low but not zero.

It raises the level of dopamine in the brain and switches on several brain systems that regulate wakefulness. It can cause severe skin and hypersensitivity reactions, mostly in the first weeks, so the official prescribing information carries a prominent warning about them. Anxiety, insomnia and, rarely, mania or hallucinations can also occur, especially in people with a psychiatric history. It can weaken the effect of hormonal contraceptives. It is not recommended in pregnancy or while breastfeeding.

ATC code

N06BA07

Prescription

Prescription only (Rx), DEA Schedule IV (USA)

Mechanism

DAT inhibitor + histamine/orexin activation

Half-life

12-15 h

Onset

30-60 min, peak 2-4 h

Data console

Lab data

ATC codeN06BA07
PrescriptionPrescription only (Rx), DEA Schedule IV (USA), specialist recommended in HU
MechanismSelective low-affinity dopamine transporter (DAT)…
Half-life12-15 h (parent); R-modafinil 14-16 h, S-modafinil 4-5 h (armodafinil = R-enantiomer)
Onset30-60 min, peak plasma 2-4 h
BioavailabilityNot determined (aqueous insolubility precludes IV); oral tablet ≈ aqueous suspension – FDA Provigil label

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Serious skin and hypersensitivity reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, multi-organ hypersensitivity), typically in the first 1–4 weeks, FDA serious warning, stop immediately at any rash.
  • Psychiatric effects: anxiety, irritability, insomnia, and less commonly mania, psychosis, hallucinations, aggression and suicidal ideation, especially with a psychiatric history.
  • Cardiovascular effects: mild increases in blood pressure and heart rate, palpitations, rarely chest pain and arrhythmia; blood pressure monitoring advised.
  • Headache (the most common, around 35%), usually easing after the first week.
  • Nausea, dry mouth, decreased appetite and weight loss.
  • Insomnia if dosed too late in the day (around ≥2 pm), so once-daily morning dosing is recommended.
  • Psychological dependence and abuse potential (DEA Schedule IV, low but not zero), especially when tied to performance expectations; physical tolerance is rare.

Contraindications · 4

  • Prior severe skin reaction (Stevens-Johnson syndrome, TEN, DRESS) history
  • Severe CV disease: LV hypertrophy, mitral valve prolapse with IHSS
  • Known modafinil hypersensitivity
  • Psychosis, severe anxiety disorder (relative)

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Modafinil?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.